Joined March 2019
- Tweets 77
- Following 144
- Followers 150
- Likes 201
3 Photos and videos
Peter Rahfeld retweeted
5 Jun 2023
Great talk by @PRahfeld at the #ATC2023SanDiego about ABOi #kidney #transplant. Let's act of the donor and not on the recipient!
3
1
5
388
Peter Rahfeld retweeted
5 Jun 2023
@PRahfeld of @ubcmsl / @AvivoBio presents fascinating data on proof of concept for blood group conversion for human kidneys using ex-vivo machine perfusion at #ATC2023SanDiego
2
3
561
Peter Rahfeld retweeted
5 Jun 2023
Conversion of kidneys to be universal donors. @PRahfeld #ATC2023SanDiego
Future opinions for solid organ transplantation @AvivoBio
3
2
10
773
Peter Rahfeld retweeted
7 May 2023
Dreaming of a green 🌍💚 and bright future ? ☘️ 🦠🧫
Listen to a new episode of #Benchtalks featuring #SarahDAdamo and @IrmischSandra and dive into the how, what, why of engineering green life using #synbio.
🎙️Link: tinyurl.com/4ye7j7ae
1
4
18
2,374
Peter Rahfeld retweeted
2 Feb 2023
Halle – Vancouver – Leiden. 🛫 #MLU-Alumnus Dr. @prahfeld hat nach seinem Biochemie-Studium an der Uni Halle in Kanada ein Biotech-Unternehmen mitgegründet, das der 37-Jährige heute aus den Niederlanden leitet. mlu.de/7t0gi
ALT Porträtfoto von Dr. Peter Rahfeld: Ein junger Mann mit halblangem, blonden Haar, der ein blau kariertes Hemd trägt.
2
13
1,310
Peter Rahfeld retweeted
21 Nov 2022
#UBC researchers have developed a process that could make #blood types obsolete.
@JayKizLab @CBR_UBC @UBCChem @ubcmsl @PRahfeld @withlabb
#BloodResearch #HealthResearch #transplant #BloodTransfusion
bit.ly/universal-blood
6
12
Peter Rahfeld retweeted
26 Oct 2022
@AvivoBio is seeking a Technician, Process Development to support the development of upstream and downstream processes, as well as impurity assay development to support the ongoing development of bacterial-produced enzyme-based product. Link: bit.ly/3W0hjST
3
3
Peter Rahfeld retweeted
20 Sep 2022
ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: avivobio.com/ and be sure to play the video on the homepage.
5
11
Peter Rahfeld retweeted
5 Aug 2022
We’re hiring! We are looking for a Project Manager and a Technician to join us on our journey to make blood types obsolete for blood transfusions and organ transplants. Postings listed at the @lifesciences_bc job board lifesciencesbc.ca/jobs/job-b…
5
9
Peter Rahfeld retweeted
12 May 2022
Haiming Luo from @UBC presenting on engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection.
#CGSBanff #glycotime @JayKizLab
1
2
7
Peter Rahfeld retweeted
12 May 2022
Daniel Luo from @JayKizLab talks about engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection!!! #glycotime
2
2
11
11 May 2022
Lars Kruse @the_real_larsk @BohlmannLab did present latest results on the production of Montbretin A, a anti-diabetic compound, at the GlycoNet Symposium @glyconet_nce. Great Talk !
#CGSBanff
1
8
Peter Rahfeld retweeted
29 Mar 2022
Our review on Carbohydrate-active enzymes in the gut microbiome is live! @withlabb @jacobwardman1 @PRahfeld #glycotime
29 Mar 2022
Carbohydrate-active enzymes (CAZymes) in the gut microbiome
rdcu.be/cJ4Qy
Withers and colleagues discuss the vast diversity and activities of CAZymes and their potential applications.
3
10
56
Peter Rahfeld retweeted
29 Mar 2022
So happy to get this review out with @rheabains @PRahfeld @withlabb! Move over hot girl summer, it's Carbohydrate-Active Enzyme spring 🤓!
29 Mar 2022
Carbohydrate-active enzymes (CAZymes) in the gut microbiome
rdcu.be/cJ4Qy
Withers and colleagues discuss the vast diversity and activities of CAZymes and their potential applications.
4
22
Peter Rahfeld retweeted
18 Feb 2022
Understanding how sugars (glycans) influence blood type and organ donor compatibility is enabling incredible innovations in #health. Exciting work from GlycoNet researchers @withlabb @JayKizLab @PRahfeld @LjwestWest & others.
#glycotime #glycomics
16 Feb 2022
A new study by Canadian scientists has proven it's possible to convert #blood type safely in donor organs intended for transplantation.
science.ubc.ca/news/creating…
#UBC @UBCChem @ABOzymes @UHNTransplant #Transplant
7
12
Peter Rahfeld retweeted
16 Feb 2022
🅾️A new study shows it's possible to convert #blood type safely in donor organs intended for #transplantation.
Dr. Jayachandran Kizhakkedathu (@JayKizLab) - as well as collaborators @PRahfeld, @withlabb, & many others - are part of this exciting work.
ow.ly/xtqK50HX4A9
1
7
13
Peter Rahfeld retweeted
24 Jan 2022
PhD vacancy, 1 week left to apply! Come and work with us on this beautiful plant, below ground even more fascinating. Details here: universiteitleiden.nl/en/vac…
#PlantSciJobs #PlantScience #PhDposition #vacancy @LeidenBiology @UniLeiden
11
18
Peter Rahfeld retweeted
7 Jan 2022
Looking forward to virtually attending and presenting on behalf of @ABOzymes!
7 Jan 2022
There are more than 2400 people registered for the upcoming #BiotechShowcase. It's just two days away but there's still time to request your meetings! See here >> bit.ly/3joEFjw @demycolton @EBDgroup
2
3
Peter Rahfeld retweeted
17 Dec 2021
VACANCY: Fully funded PhD position in my lab. Fascinated by plant specialized metabolism? Come and work with us! #PlantScience #PlantSciJobs @LeidenBiology @UniLeiden
-> study regulation and transport of a novel anti-diabetic plant derived metabolite universiteitleiden.nl/en/vac…
56
68
Peter Rahfeld retweeted
10 Nov 2021
GlycoNet's Dr. Stephen Withers @UBC is leading Phase 1 trial of a new anti-diabetic compound. By slowing starch breakdown, it could be used to help manage Type 2 #diabetes w/ fewer side effects than other treatments.
Read more: bit.ly/3F4h6VA
#WorldDiabetesDay #Glycomics
2
5
19